Literature DB >> 12011895

The teratogenicity of drugs for nausea and vomiting of pregnancy: perceived versus true risk.

Gideon Koren1, Zina Levichek.   

Abstract

Women and health care providers commonly overestimate the teratogenic risk of medications in pregnancy. With regard to nausea and vomiting of pregnancy, this leads to an underutilization of pharmacologic therapy. Pregnancy termination has even been elected in some circumstances when safe and effective alternatives for nausea have not been attempted. The misperception of teratogenic risk is partly the result of the way data on safety are presented. An awareness of this can lead to more balanced patient and physician educational materials. To facilitate rational use of medicinal and nonmedicinal therapy for nausea and vomiting of pregnancy, we have developed an algorithm based on a recent systematic review of safety and efficacy in management of the problem. The hierarchical use of medication is based on strength of evidence of fetal safety.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011895     DOI: 10.1067/mob.2002.122601

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Exploring the Design and Role of Mobile Apps for Healthcare Providers to Find Teratogenic Information.

Authors:  Lily Lie; Vishwas Shetty; Karan Gupta; Janine E Polifka; Glen Markham; Sarah Albee; Carol Collins; Gary Hsieh
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

Review 2.  Interventions for nausea and vomiting in early pregnancy.

Authors:  Anne Matthews; Therese Dowswell; David M Haas; Mary Doyle; Dónal P O'Mathúna
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

3.  Placental transfer of ondansetron during early human pregnancy.

Authors:  Shing-Shun N Siu; Matthew T V Chan; Tze-Kin Lau
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.

Authors:  Sofia Frost Widnes; Jan Schjøtt; Geir Egil Eide; Anne Gerd Granas
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

5.  Drug use in pregnancy: Knowledge of drug dispensers and pregnant women in Dar es Salaam, Tanzania.

Authors:  Appolinary Kamuhabwa; Rashida Jalal
Journal:  Indian J Pharmacol       Date:  2011-05       Impact factor: 1.200

6.  Review of NVP and HG and Early Pharmacotherapeutic Intervention.

Authors:  Shannon M Clark; Maged M Costantine; Gary D V Hankins
Journal:  Obstet Gynecol Int       Date:  2011-11-24

Review 7.  The Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy.

Authors:  Iñaki Lete; José Allué
Journal:  Integr Med Insights       Date:  2016-03-31

8.  Nausea in pregnancy: attitudes among pregnant women and general practitioners on treatment and pregnancy care.

Authors:  Kristine Heitmann; Hans Christian Svendsen; Ingvild H Sporsheim; Lone Holst
Journal:  Scand J Prim Health Care       Date:  2016-02-08       Impact factor: 2.581

9.  Risks versus benefits of medication use during pregnancy: what do women perceive?

Authors:  Bianca Mulder; Maarten J Bijlsma; Catharina Cm Schuiling-Veninga; Leonard P Morssink; Eugene van Puijenbroek; Jan G Aarnoudse; Eelko Hak; Tjalling W de Vries
Journal:  Patient Prefer Adherence       Date:  2017-12-20       Impact factor: 2.711

Review 10.  Interventions for nausea and vomiting in early pregnancy.

Authors:  Anne Matthews; David M Haas; Dónal P O'Mathúna; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.